281 related articles for article (PubMed ID: 24931899)
21. Prognostic value of plasma human β-defensin 2 level on short-term clinical outcomes in patients with community-acquired pneumonia: a preliminary study.
Liu S; He LR; Wang W; Wang GH; He ZY
Respir Care; 2013 Apr; 58(4):655-61. PubMed ID: 23051183
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and significance of various scores for pneumonia severity in the management of patients with community-acquired pneumonia in China.
Yang Y; Xu F; Shi LY; Diao R; Cheng YS; Chen XY; Jing JY; Wang XD; Shen HH
Chin Med J (Engl); 2012 Feb; 125(4):639-45. PubMed ID: 22490488
[TBL] [Abstract][Full Text] [Related]
23. Early identification of severe community-acquired pneumonia: a retrospective observational study.
Grudzinska FS; Aldridge K; Hughes S; Nightingale P; Parekh D; Bangash M; Dancer R; Patel J; Sapey E; Thickett DR; Dosanjh DP
BMJ Open Respir Res; 2019; 6(1):e000438. PubMed ID: 31258921
[TBL] [Abstract][Full Text] [Related]
24. Red blood cell distribution width [RDW] and long-term mortality after community-acquired pneumonia. A comparison with proadrenomedullin.
Bello S; Fandos S; Lasierra AB; Mincholé E; Panadero C; Simon AL; Gavin O; De Pablo F; Menendez R; Torres A
Respir Med; 2015 Sep; 109(9):1193-206. PubMed ID: 26205553
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic accuracy of presepsin (soluble CD14 subtype) for prediction of bacteremia in patients with systemic inflammatory response syndrome in the Emergency Department.
Romualdo LG; Torrella PE; González MV; Sánchez RJ; Holgado AH; Freire AO; Acebes SR; Otón MD
Clin Biochem; 2014 May; 47(7-8):505-8. PubMed ID: 24560955
[TBL] [Abstract][Full Text] [Related]
26. The CURB65 pneumonia severity score outperforms generic sepsis and early warning scores in predicting mortality in community-acquired pneumonia.
Barlow G; Nathwani D; Davey P
Thorax; 2007 Mar; 62(3):253-9. PubMed ID: 16928720
[TBL] [Abstract][Full Text] [Related]
27. Usefulness of plasma neutrophil gelatinase-associated lipocalin concentration for predicting the severity and mortality of patients with community-acquired pneumonia.
Kim JW; Hong DY; Lee KR; Kim SY; Baek KJ; Park SO
Clin Chim Acta; 2016 Nov; 462():140-145. PubMed ID: 27662812
[TBL] [Abstract][Full Text] [Related]
28. Serum suPAR and syndecan-4 levels predict severity of community-acquired pneumonia: a prospective, multi-centre study.
Luo Q; Ning P; Zheng Y; Shang Y; Zhou B; Gao Z
Crit Care; 2018 Jan; 22(1):15. PubMed ID: 29368632
[TBL] [Abstract][Full Text] [Related]
29. Validation and comparison of SCAP as a predictive score for identifying low-risk patients in community-acquired pneumonia.
España PP; Capelastegui A; Quintana JM; Bilbao A; Diez R; Pascual S; Esteban C; Zalacaín R; Menendez R; Torres A
J Infect; 2010 Feb; 60(2):106-13. PubMed ID: 19961875
[TBL] [Abstract][Full Text] [Related]
30. Soluble CD14 Subtype-A New Biomarker in Predicting the Outcome of Critically Ill Septic Patients.
Matera G; Quirino A; Peronace C; Settembre P; Marano V; Loria MT; Marascio N; Galati L; Barreca GS; Giancotti A; Amantea B; Liberto MC; Focà A
Am J Med Sci; 2017 Jun; 353(6):543-551. PubMed ID: 28641717
[TBL] [Abstract][Full Text] [Related]
31. Presepsin (sCD14-ST) in emergency department: the need for adapted threshold values?
Chenevier-Gobeaux C; Trabattoni E; Roelens M; Borderie D; Claessens YE
Clin Chim Acta; 2014 Jan; 427():34-6. PubMed ID: 24076253
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic and prognostic value of presepsin in the management of sepsis in the emergency department: a multicenter prospective study.
Ulla M; Pizzolato E; Lucchiari M; Loiacono M; Soardo F; Forno D; Morello F; Lupia E; Moiraghi C; Mengozzi G; Battista S
Crit Care; 2013 Jul; 17(4):R168. PubMed ID: 23899120
[TBL] [Abstract][Full Text] [Related]
33. Endothelin-1 precursor peptides correlate with severity of disease and outcome in patients with community acquired pneumonia.
Schuetz P; Stolz D; Mueller B; Morgenthaler NG; Struck J; Mueller C; Bingisser R; Tamm M; Christ-Crain M
BMC Infect Dis; 2008 Feb; 8():22. PubMed ID: 18304365
[TBL] [Abstract][Full Text] [Related]
34. [CCERW: a new rule to predict treatment failure in patients with community-acquired pneumonia in middle aged and elderly people].
Li JS; Li SY; Yu XQ; Sun ZK; Zhang W; Jia XH; Zheng SP; Wang MH; Wang HF
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2011 Jan; 23(1):10-7. PubMed ID: 21251359
[TBL] [Abstract][Full Text] [Related]
35. Prognosis of community acquired pneumonia (CAP): value of triggering receptor expressed on myeloid cells-1 (TREM-1) and other mediators of the inflammatory response.
Tejera A; Santolaria F; Diez ML; Alemán-Valls MR; González-Reimers E; Martínez-Riera A; Milena-Abril A
Cytokine; 2007 Jun; 38(3):117-23. PubMed ID: 17659879
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic and prognostic value of presepsin in the emergency department.
Popa TO; Cimpoeşu D; Dorobăţ CM
Rev Med Chir Soc Med Nat Iasi; 2015; 119(1):69-76. PubMed ID: 25970945
[TBL] [Abstract][Full Text] [Related]
37. Pro-atrial natriuretic peptide and pro-vasopressin for predicting short-term and long-term survival in community-acquired pneumonia: results from the German Competence Network CAPNETZ.
Krüger S; Ewig S; Kunde J; Hartmann O; Suttorp N; Welte T;
Thorax; 2010 Mar; 65(3):208-14. PubMed ID: 20335288
[TBL] [Abstract][Full Text] [Related]
38. Pneumococcal pneumonia - Are the new severity scores more accurate in predicting adverse outcomes?
Ribeiro C; Ladeira I; Gaio AR; Brito MC
Rev Port Pneumol; 2013; 19(6):252-9. PubMed ID: 23850193
[TBL] [Abstract][Full Text] [Related]
39. Severity assessment tools for predicting mortality in hospitalised patients with community-acquired pneumonia. Systematic review and meta-analysis.
Chalmers JD; Singanayagam A; Akram AR; Mandal P; Short PM; Choudhury G; Wood V; Hill AT
Thorax; 2010 Oct; 65(10):878-83. PubMed ID: 20729231
[TBL] [Abstract][Full Text] [Related]
40. Validity of SMART-COP score in prognosis and severity of community acquired pneumonia in the emergency department.
Ehsanpoor B; Vahidi E; Seyedhosseini J; Jahanshir A
Am J Emerg Med; 2019 Aug; 37(8):1450-1454. PubMed ID: 30401592
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
